SweetTaste: Sensory Study: Taste and Tongue Biology

Sponsor
University of Massachusetts, Amherst (Other)
Overall Status
Completed
CT.gov ID
NCT05985928
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH)
121
1
2
60.4

Study Details

Study Description

Brief Summary

Researchers will investigate the correlation between a) self-reported dietary intake of foods and beverages, b) intensity of sucrose stimuli, and c) liking rating of sweet stimuli, with the relative expression of the taste receptor genes from human fungiform papillae (TAS1R2 and TAS1R3).

  • This research will provide new information on how sweet taste perception is regulated.
  • The hypothesis: Greater dietary consumption of sugar and sweet foods is associated with reduced expression of the sweet taste receptors.

  • The results of this study could help to identify pathways to help modify sweet taste perception by uncovering this mechanism.

Participants will sample solutions prepared with sweet ingredients, provide salivary DNA, and collect fungiform papillae. This will allow researchers and investigators to compare the relationship between the sweetness of stimuli, genetic differences in sweet taste receptors, and expression levels of sweet taste receptor genes.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    121 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Sensory Study: Taste and Tongue Biology
    Actual Study Start Date :
    Mar 20, 2023
    Actual Primary Completion Date :
    May 20, 2023
    Actual Study Completion Date :
    May 20, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Gene expression and sweet taste perception [Day 1 (single time-point)]

      The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (gLMS ratings of sampled sucrose)

    2. Gene expression and sweet taste liking [Day 1 (single time-point)]

      The relative level of gene expression of sweet taste receptors (TAS1R2 and TAS1R3) and relationship with sweet taste perception (hedonic ratings of sampled sucrose)

    3. Gene expression and dietary intake [Day 1 (single time-point)]

      The relative gene level expression of sweet taste receptors and relationship with self-reported dietary intake of sweet foods and beverages

    4. Gene expression and sweet liker status [Day 1 (single time-point)]

      The relative gene level expression of sweet taste receptors and relationship with the self-reported liking of a variety of sweet foods and beverages

    Secondary Outcome Measures

    1. Genetics and sweet taste perception [Day 1 (single time-point)]

      Genetic variability in sweet taste receptor genes and the relationship with perception of sweet stimuli (gLMS intensity ratings)

    2. Genetics and sweet taste liking [Day 1 (single time-point)]

      Genetic variability in sweet taste receptor genes and the relationship with hedonic ratings of sweet stimuli (hedonic ratings)

    3. Genetics and sweet liker status [Day 1 (single time-point)]

      Genetic variability in sweet taste receptor genes and the relationship with the self-reported liking of sweet-tasting foods and beverages

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. between 18 and 45 years old,

    2. have no tongue or cheek piercings,

    3. not a user of tobacco products or electronic cigarettes (within the last year),

    4. no known defects in taste or smell,

    5. not pregnant or breastfeeding,

    6. no history of chronic pain in the mouth,

    7. not taking any prescription pain medication,

    8. not taking any blood thinners,

    9. no history of cancer or cancer treatment,

    10. not diabetic or restricting intake of sugars for medical reasons, under the direction of a physician or healthcare provider

    11. willing to undergo the Fungiform Papillae biopsy procedure

    12. willing to provide salivary DNA

    13. Not currently experiencing any COVID-19 symptoms

    14. Not recently diagnosed (in the last 30 days) with COVID-19

    15. No history of high blood pressure

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Massachusetts Amherst Massachusetts United States 01003

    Sponsors and Collaborators

    • University of Massachusetts, Amherst
    • National Institute on Deafness and Other Communication Disorders (NIDCD)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Massachusetts, Amherst
    ClinicalTrials.gov Identifier:
    NCT05985928
    Other Study ID Numbers:
    • 2587
    • R21DC018906
    First Posted:
    Aug 14, 2023
    Last Update Posted:
    Aug 14, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Massachusetts, Amherst

    Study Results

    No Results Posted as of Aug 14, 2023